RESPIRERX PHARMA INC (RSPI)
RSPI moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How RSPI actually reacts to news — the realized, point-in-time move the market made, measured across 28 labeled events over the last three years with zero look-ahead.
RSPI’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 26% | 19 |
| 30-min | 0.00% | 37% | 19 |
| 60-min | 0.00% | 37% | 19 |
| to close | 0.00% | 29% | 17 |
Small sample: only 28 measured events — treat these medians as indicative, not stable.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when RSPI moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to RSPI's baseline. Nothing else.
Recent RSPI events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties | Press release | GlobeNewswire | — | — | |
| RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties | Press release | GlobeNewswire | — | — | |
| RespireRx Pharmaceuticals Inc. Announces NIH/NINDS Grant Award and Amended and Restated Patent License Agreement | Press release | GlobeNewswire | — | — | |
| RespireRx Pharmaceuticals Inc. Announces Commencement of Rule 506(c) Private Placement | Press release | GlobeNewswire | — | — | |
| RespireRx Pharmaceuticals Inc. Announces SEC Order Making Findings and Revoking Registration of Securities and Future Plans with respect to its Common Stock | Press release | GlobeNewswire | — | — | |
| Form REVOKED RespireRx Pharmaceutical | SEC filing · Form REVOKED | SEC EDGAR | — | — | |
| Form 8-K RespireRx Pharmaceutical For: Feb 10 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties | Press release | GlobeNewswire | — | — | |
| Form 8-K RespireRx Pharmaceutical For: Aug 30 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K RespireRx Pharmaceutical For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K RespireRx Pharmaceutical For: Jul 02 | SEC filing · Form 8-K | SEC EDGAR | -11.77% | -5.88% | |
| Form 8-K RespireRx Pharmaceutical For: May 29 | SEC filing · Form 8-K | SEC EDGAR | +22.73% | — | |
| RespireRx Pharmaceuticals Inc. Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Determine the Safety and Efficacy of CX1739, its Lead AMPAkine, to Improve Bladder Function in Patients with Spinal Cord Injury | Press release | GlobeNewswire | +22.73% | — | |
| Form 8-K RespireRx Pharmaceutical For: Apr 10 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -10.00% | |
| Form NT 10-K RespireRx Pharmaceutical For: Dec 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | -10.00% | |
| RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury | Press release | GlobeNewswire | +0.00% | +25.00% | |
| RespireRx Pharmaceuticals Inc. Reports Preclinical Pain Relief for their Non-Opioid Lead GABAkine | Press release | GlobeNewswire | +0.00% | +25.00% | |
| Form 8-K RespireRx Pharmaceutical For: Jan 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -10.00% | |
| Form 8-K RespireRx Pharmaceutical For: Jan 18 | SEC filing · Form 8-K | SEC EDGAR | -7.14% | +42.86% | |
| RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors | Press release | GlobeNewswire | -7.14% | +42.86% | |
| RespireRx Pharmaceuticals Inc. Announces the Publication of a Case Report in which KRM-II-81 Totally Suppressed Epileptiform Activity in Brain Tissue Surgically Removed from Epileptic Patient | Press release | GlobeNewswire | +10.00% | +0.00% | |
| Form 8-K RespireRx Pharmaceutical For: Dec 06 | SEC filing · Form 8-K | SEC EDGAR | -5.46% | -23.64% | |
| RespireRx Pharmaceuticals Inc. Announces Agreement with Ponto Ventures to Drive Business Development with Will Clodfelter as RespireRx Part-Time Senior VP of Business Development | Press release | GlobeNewswire | -5.46% | -23.64% | |
| Form 10-Q RespireRx Pharmaceutical For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +10.00% | |
| Form NT 10-Q RespireRx Pharmaceutical For: Sep 30 | SEC filing · Form NT | SEC EDGAR | +0.00% | +0.00% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the RSPI section they belong to.
Where else RSPI is measured.
RSPI earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Evelo Biosciences, Inc. (EVLO) | 28 | -3.02% | 36% |
| Nu-Med Plus Inc. Com (NUMD) | 28 | 0.00% | 41% |
| Axim Biotechnologies, Inc (AXIM) | 27 | 0.00% | 16% |
| Crescita Therapeutics Inc (CTX_TSE) | 27 | 0.00% | 22% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is RESPIRERX PHARMA INC's median reaction calculated?
Every labeled RSPI news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 28 events is what this page reports. On a sample this small (28 events), treat these medians as indicative, not stable. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does RSPI's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.